Summary
In an attempt to reduce postoperative sepsis, a series of randomised, double-blind studies was begun in 1982, using cefotaxime as backbone therapy. Up to 1985 (stages I and II), the best results were obtained using a combination of cefotaxime (75 mg/kg intravenously in 3 doses at 12-hourly intervals) plus metronidazole (10 mg/kg intravenously in 3 doses), both drugs administered 1 hour before surgery (preoperatively) or at anaesthetic induction (perioperatively). In 300 consecutive cases, the wound infection rates were 1% in uncomplicated acute appendicitis and 5% in perforated/gangrenous appendices.
The present study (stage III) reports the findings in 401 consecutive patients: 215 treated with the above regimen, either pre-or perioperatively (group 1) and 186 who additionally had peritoneal lavage with cefotaxime 2 g/L during surgery (group 2). There were 16 wound infections overall, 2 among patients administered prophylaxis preoperatively and 14 in those administered prophylaxis perioperatively. All produced mixed cultures, with Escherichia coli, Streptococcus milleri and Bacteroides fragilis predominating. The overall figures for postoperative sepsis are 12/215 (5.6%) in the non-lavage group and 8/186 (4.3%) in the lavage group. Among patients with a perforated and/or gangrenous appendix, the wound infection rate was 8/72 (11.1% ) in the non-lavage group (group 1) and 4/66 (6.1%) in the lavage group (group 2). Each group had 2 cases of pelvic abscess.
Similar content being viewed by others
References
Berne TV, Yellin AW, Appleman MD, Heseltine PNR. Antibiotic management of surgically treated gangrenous or perforated appendicitis. American Journal of Surgery 144: 8–13, 1982
Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 50: 161–168, 1961
Campbell WN. Prophylaxis of infection after appendicectomy: a survey of current clinical practice. British Medical Journal 281: 1597–1600, 1980
Chiam HL, Chee CP, Cheak KC, Semasundaram K, Putchu-cheary SD. The prevention of postappendectomy sepsis by metronidazole and cotrimoxazole: a controlled double-blind trial. Australian and New Zealand Journal of Surgery 53: 421–425, 1983
Danish Multicenter Study Group. A Danish multicenter study: cefoxitin versus ampicillin and metronidazole in perforated appendicitis. British Journal of Surgery 71: 144–146, 1984
Di Piro JT, Bivins BA, Record KE, Bil RM, Gaiffen WO. The prophylactic use of antimicrobials in surgery. Current Problems in Surgery 20: 76–132, 1983
Donovan IA, Ellis D, Gatehouse D, Little G, Grimly R, et al. One dose antibiotic prophylaxis against wound infection after appendicectomy. A randomized trial of clindamycin, cefazolin sodium and a placebo. British Journal of Surgery 66: 193–196, 1979
Evans M, Pollock AV. A score system for evaluating random control clinical trials of prophylaxis of abdominal surgical wound infection. British Journal of Surgery 72: 256–260, 1985
Favre JP, Bouchet Y, Clotteau JE, Hypousteguy L, Marchal G, et al. Prophylactic use of cefotaxime in colonie and rectal surgery. Journal of Antimicrobial Chemotherapy 14 (Suppl. B): 247–253, 1984
Fine M, Busuttil RW. Acute appendicitis: efficacy of prophylactic preoperative antibiotic in the reduction of septic morbidity. American Journal of Surgery 135: 210–212, 1978
Giacomantonio M, Bortolussi R, Gillis DA. Should prophylactic antibiotics be given perioperatively in acute appendicitis without perforation? Canadian Journal of Surgery 25: 555–556, 1982
Gilmore OJA, Martin TDM. Etiology and prevention of wound infection in appendectomy. British Journal of Surgery 61: 281–287, 1974
Keighley MRB. Indications for chemoprophylaxis. In Karran (Ed.) Controversies in Surgical Sepsis, pp. 87–93, Praeger, New York, 1980
Lau WY, Fan ST, Chu KW, Suen HC, Yiu TF, et al. Randomized prospective, and double-blind trial of new beta-lactams in the treatment of appendicitis. Antimicrobial Agents and Chemotherapy 28: 639–642, 1985
Lau WY, Fan ST, Chu KW, Yip WC, Yiu TF, et al. Cefoxitin versus gentamicin and metronidazole in prevention of post-appendicectomy sepsis: a randomized prospective trial. Journal of Antimicrobial Chemotherapy 18: 613–619, 1986
Leigh DA, Simmons K, Norman E. Bacterial flora of the appendix fossa in appendicitis and postoperative wound infection. Journal of Clinical Pathology 27: 997–1000, 1974
Louie TJ, Blanchard R, Yaffe C, Lertzman J, McLeod J. Randomized, double-blind comparison of cefotaxime, cefoxitin, cefazolin or placebo as prophylaxis during gastric, small bowel or complicated biliary surgery. Journal of Antimicrobial Chemotherapy 14 (Suppl. B): 255–262, 1984
Magarey CJ, Chant ABD, Richford CRK, Magarey JR. Peritoneal drainage and systemic antibiotics after appendectomy. Lancet II: 179–182, 1971
McAllister TA, Fyfe AHB, Young DG, Raine PAM. Randomized double-blind studies of cefotaxime in children undergoing appendicectomy. In Neu (Ed.) Proceedings of the 14th International Congress of Chemotherapy, Kyoto, June 23–28, 1985, pp. 69–75, Excerpta Medica, Amsterdam, 1985
Miles AA, Miles EM, Burke J. The value and duration of defence reaction of the skin to the primary lodgement of bacteria. British Journal of Experimental Pathology 38: 79–96, 1957
Morris WT, Innes DB, Richardson RA, Lee AJ, Ellis-Pegler RB. The prevention of postappendicectomy sepsis by metronidazole and cefazolin: a controlled double-blind trial. Australian and New Zealand Journal of Surgery 50: 429–433, 1980
Neu HC, Aswapokee N, Aswapokee P, Fu KP. HR 756, a new cephalosporin active against Gram-positive and Gram-negative bacteria. Antimicrobial Agents and Chemotherapy 15: 273–278, 1979
Richmond MH. Beta-lactamase stability of cefotaxime. Journal of Antimicrobial Chemotherapy 6 (Suppl. A): 13–17, 1980
Sanders CC. Emerging problems of resistance to the newer cephalosporins: clinical significance. Internal Medicine for the Specialist 5: 1–5, 1984
Selkon JB. Use and abuse of chemoprophylaxis. In Evans (Ed.) Serious infections — treatment and prevention, pp. 45–46, Update Books, London, 1983
Shah PM, Troche G, Stillew. In vitro activity of HR 756, a new cephalosporin compound. Journal of Antibiotics 31: 1170–1174, 1978
Smith CR, Ambinder R, Lipsky JJ, Petty BG, Israel E, et al. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. Annals of Internal Medicine 101: 469–477, 1984
Strachan CJL. Systemic prophylaxis. In Karran (Ed.) Controversies in Surgical Sepsis, pp. 159–168, Praeger, New York, 1980
Wise R, Wills PJ, Andrews JM, Bedford KA. Activity of the cefotaxime metabolite compared with those of cefotaxime and other cephalosporins. Antimicrobial Agents and Chemotherapy 17: 84–86, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McAllister, T.A., Fyfe, A.H.B., Young, D.G. et al. Cefotaxime Lavage in Children Undergoing Appendicectomy. Drugs 35 (Suppl 2), 127–132 (1988). https://doi.org/10.2165/00003495-198800352-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800352-00027